KLP Kapitalforvaltning AS Purchases 3,600 Shares of Omega Healthcare Investors, Inc. $OHI

KLP Kapitalforvaltning AS boosted its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 5.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 73,100 shares of the real estate investment trust’s stock after acquiring an additional 3,600 shares during the period. KLP Kapitalforvaltning AS’s holdings in Omega Healthcare Investors were worth $2,679,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in OHI. Belpointe Asset Management LLC lifted its position in Omega Healthcare Investors by 4.2% during the second quarter. Belpointe Asset Management LLC now owns 16,936 shares of the real estate investment trust’s stock valued at $621,000 after buying an additional 690 shares during the period. DAVENPORT & Co LLC raised its position in shares of Omega Healthcare Investors by 10.4% in the 2nd quarter. DAVENPORT & Co LLC now owns 12,740 shares of the real estate investment trust’s stock worth $467,000 after purchasing an additional 1,197 shares during the last quarter. 111 Capital purchased a new position in shares of Omega Healthcare Investors in the 2nd quarter worth about $803,000. Vanderbilt University purchased a new position in Omega Healthcare Investors in the 2nd quarter worth about $1,316,000. Finally, Rainey & Randall Wealth Advisors Inc. raised its position in Omega Healthcare Investors by 1.5% in the 2nd quarter. Rainey & Randall Wealth Advisors Inc. now owns 191,372 shares of the real estate investment trust’s stock worth $7,014,000 after buying an additional 2,736 shares during the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

OHI opened at $39.83 on Friday. Omega Healthcare Investors, Inc. has a 12-month low of $35.04 and a 12-month high of $44.42. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The business’s fifty day simple moving average is $41.57 and its 200-day simple moving average is $38.81. The company has a market capitalization of $11.75 billion, a price-to-earnings ratio of 24.59, a PEG ratio of 1.86 and a beta of 0.70.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. During the same quarter in the prior year, the company earned $0.71 EPS. The business’s revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, equities research analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were given a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.7%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 165.43%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on OHI. Raymond James Financial restated an “outperform” rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Omega Healthcare Investors in a report on Wednesday. Cantor Fitzgerald assumed coverage on Omega Healthcare Investors in a report on Wednesday, October 1st. They set an “overweight” rating and a $50.00 price objective on the stock. Mizuho upped their price objective on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a report on Thursday, September 11th. Finally, Royal Bank Of Canada upped their price objective on Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a “sector perform” rating in a report on Thursday, August 7th. Seven equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $44.44.

Insiders Place Their Bets

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director owned 18,654 shares of the company’s stock, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.50% of the company’s stock.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.